首页|结直肠癌患者化疗所致骨髓抑制与中医体质的相关研究

结直肠癌患者化疗所致骨髓抑制与中医体质的相关研究

扫码查看
目的:本研究通过对结直肠癌并行卡培他滨+奥沙利铂(XELOX)化疗方案的患者进行中医体质辨识,探讨中医体质与XELOX化疗方案所引起的骨髓抑制的内在相关性,明确其对骨髓抑制发生的预测意义.方法:选取2020年10月-2022年8月于临沂市中医医院肛肠科就诊并诊断为结直肠癌的患者,共80例.在化疗前,通过中医体质辨识问卷对所有入组患者进行体质辨识,后予以XELOX化疗方案进行化疗,化疗4个周期后统计骨髓抑制的发生情况,并运用Logistic回归进行统计分析,探讨结直肠癌患者不同中医体质类型与骨髓抑制发生情况的内在联系.结果:在所有中医体质类型中,气郁质患者的骨髓抑制发生率最高,湿热质患者次之.其中,气郁质患者共16例,发生骨髓抑制者11例,占比68.75%(11/16);湿热质患者共25例,发生骨髓抑制者16例,占比64.00%(16/25).气郁质患者的骨髓抑制程度主要为2度,共6例,占比37.5%(6/16);湿热质患者的骨髓抑制程度主要为1度,共9例,占比36.0%(9/25).运用Logistic回归统计分析发现,气郁质[P=0.033,比值比(Odds Ratiio,OR)=13.2,95%置信区 间(Confidence Interval,CI):1.239~140.679]和湿热质(P=0.041,OR=10.667,95%CI:1.103~103.15)均为结直肠癌患者骨髓抑制发生的危险因素.结论:中医体质可以预测XELOX化疗所引起的骨髓抑制的发生,气郁质和湿热质发生骨髓抑制的概率更高.
Correlation between chemotherapy induced myelosuppression and traditional Chinese medicine constitution in patients with colorectal cancer
Objective:In this study,through the identification of traditional Chinese medicine constitution in patients with colorectal cancer who were treated with capecitabine plus oxaliplatin(XELOX)chemotherapy regimen,the intrinsic correlation between TCM constitution and myelosuppression induced by XELOX chemotherapy regimen was explored,and its predictive significance for myelo-suppression was clarified.Methods:A total of 80 patients with colorectal cancer in the Department of Proctology of Linyi Hospital of Traditional Chinese Medicine from October 2020 to August 2022 were selected.Before chemotherapy,all patients were identified by the TCM constitution type identification questionnaire,and then were given XELOX chemotherapy regimen for chemotherapy.The occurrence of myelosuppression was counted after 4 cycles of chemotherapy,and Logistic regression was used for statistical analysis to explore the internal correlation between different TCM constitution types and the occurrence of myelosuppression in colorectal cancer patients.Results:Among all types of TCM con-stitution,Qi(气)stagnation constitution patients had the highest proportion of myelosuppression,followed by damp-heat constitution patients.Among them,there were 16 Qi stagnation constitution patients,and l1 damp-heat constitution patients experienced myelosuppression,accounting for 68.75%(11/16).There were 25 damp-heat constitution patients,and 16 patients experienced myelosuppression,accounting for 64.00%(16/25).The degree of myelosuppression in Qi stagnation constitution patients was mainly 2 degrees,there were 6 cases,accounting for 37.5%(6/16).The degree of myelosuppression in the damp-heat constitution patients was mainly 1 degree,there were 9 cases,accounting for 36.0%(9/25).Logistic regression statistical analysis showed that Qi stagnation constitution[P=0.033,OR=13.2,95%CI:1.239-140.679]and damp-heat constitution[P=0.041,OR=10.667,95%CI:1.103-103.15]were risk factors for myosuppression in patients with colorectal cancer.Conclusion:TCM consti-tution can predict the occurrence of myelosuppression caused by XELOX chemotherapy,and the probability of myelosuppression is higher in Qi-stagnation constitution and damp-heat constitution patients.

Colorectal cancerTCM constitutionXELOX chemotherapy regimenToxic and side effectsMyelosuppression

刘淑桢、张坤、李凤先、王志荣

展开 >

山东中医药大学,山东 济南,250014

临沂市中医医院,山东 临沂,276000

结直肠癌 中医体质 XELOX化疗方案 不良反应 骨髓抑制

山东省中医药科技项目

2020M172

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(6)